Skip to content

Exercise to improve heart and brain health following stroke

Aerobic exercise to improve cardiovascular and neurological health outcomes in the chronic stroke population

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12609000645257
Enrollment
13
Registered
2009-07-30
Start date
2009-09-01
Completion date
2014-12-05
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Aerobic exercise can improve cardiovascular fitness, mobility and physical function following stroke but it is not known whether it has an effect on cognitive and neurological function. We intend to compare a 12 week exercise program with usual care to document changes in impairment, activity and participation, as well as performing a cost-effectiveness study.

Interventions

Patients are randomised to participate in aerobic exercise three times a week for 12 weeks or usual care. The exercise classes include stations of treadmill training, stationary cycling, arm and/or leg ergometry and weight bearing exercise such as steps and overground walking and last for 1 hour. Blinded assessment of outcome is performed at baseline, 3 and 6 months.

Sponsors

University of South Australia
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
45 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Diagnosis of first or recurrent stroke, haemorrhage or infarct at least 6 months prior to entry into the study.

Exclusion criteria

Patients who are unable to participate in an exercise programme due to medical conditions such as heart failure, unstable angina, dementia and receptive aphasia. Patients on beta-blockers. Patients already participating in a supervised aerobic exercise programme. Patients who have epilepsy, metallic implants in the skull or cardiac pacemakers will be excluded from the transcranial magnetic stimulation.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026